Cofco Deferred Long Term Liab from 2010 to 2024
| 000930 Stock | 5.78 0.04 0.69% |
Deferred Long Term Liabilities | First Reported 2018-06-30 | Previous Quarter 35.5 M | Current Value 34.4 M | Quarterly Volatility 8.1 M |
Check Cofco Biochemical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cofco Biochemical's main balance sheet or income statement drivers, such as Interest Expense of 118.4 M, Selling General Administrative of 184.1 M or Total Revenue of 21.4 B, as well as many indicators such as . Cofco financial statements analysis is a perfect complement when working with Cofco Biochemical Valuation or Volatility modules.
Cofco | Deferred Long Term Liab |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Cofco Stock
Cofco Biochemical financial ratios help investors to determine whether Cofco Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cofco with respect to the benefits of owning Cofco Biochemical security.